Reduction of nitric oxide synthase 2 expression by distamycin A improves survival from endotoxemia

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 4147-4153

  Baron, Rebecca M ^a   Carvajal, Irvith M ^a   Liu, Xiaoli ^a   Okabe, Rachel O ^a   Fredenburgh, Laura E ^a   Macias, Alvaro A ^a   Chen, Yen Hsu ^a   Ejima, Kuniaki ^a   Layne, Matthew D ^a   Perrella, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DISTAMYCIN A; DNA; ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AT RICH SEQUENCE; CELL LINE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFECT; DRUG EFFICACY; ENDOTOXEMIA; HYPOTENSION; MACROPHAGE; MALE; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION;

EID: 4644294368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.4147     Document Type: Article

References (40)

1. Wheeler, A. P., and G. R. Bernard. 1999. Treating patients with severe sepsis. N. Engl. J. Med. 340:207.
2. Riedemann, N. C., R.-F. Guo, and P. A. Ward. 2003. The enigma of sepsis. J. Clin. Invest. 112:460.
3. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
4. Ejima, K., M. D. Layne, I. M. Carvajal, P. A. Kritek, R. M. Baron, Y.-H. Chen, J. Vom Saal, B. D. Levy, S.-F. Yet, and M. A. Perrella. 2003. Cyclooxygenase-2 deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J. 17:1325.
5. Laubach, V. E., P. L. Foley, K. S. Shockey, C. G. Tribble, and I. L. Kron. 1998. Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2 deficient mice. Am. J. Physiol. 275:H2211.
6. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
7. Wei, X., I. G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
8. Laubach, V. W., E. G. Shesely, W. Smithies, and P. A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92:10688.
9. Zingarelli, B., P. W. Hake, and J. A. Cook. 2002. Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in mice. Shock 17:478.
10. Nathan, C. 1997. Perspective series: nitric oxide and nitric oxide synthases: inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100:2417.
11. Cozzi, P. 2000. Recent outcome in the field of distamycin-derived minor groove binders. Il. Farmaco 55:168.
12. Bustin, M., and R. Reeves. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54:35.
13. Wegner, M., and F. Grummt. 1990. Netropsin, distamycin and berenil interact differentially with a high-affinity binding site for the high mobility group protein HMG-I. Biochem. Biophys. Res. Commun. 166:1110.
14. Garvey, E. P., J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J. Whittle, and R. G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:4959.
15. Rudkowski, J. C., E. Barreiro, R. Harfouche, P. Goldberg, O. Kishta, P. D'Orleans-Juste, J. Labonte, O. Lesur, and S. N. A. Hussain. 2004. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L793.
16. Perrella, M. A., C.-M. Hsieh, W.-S. Lee, S. Shieh, J.-C. Tsai, C. Patterson, C. J. Lowenstein, N. C. Long, E. Haber, S. Shore, and M.-E. Lee. 1996. Arrest of endotoxin-induced hypotension by transforming growth factor β1. Proc. Natl. Acad. Sci. USA 93:2054.
17. Pellacani, A., P. Wiesel, S. Razavi, V. Vasilj, M. W. Feinberg, M. T. Chin, R. Reeves, and M. A. Perrella. 2001. Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-β1. J. Biol. Chem. 276:1653.
18. Perrella, M. A., C. Patterson, L. Tan, S.-Y. Yet, C.-M. Hsieh, M. Yoshizumi, and M.-E. Lee. 1996. Suppression of interleukin-1β-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-β1 in vascular smooth muscle cells. J. Biol. Chem. 271:13776.
19. Chen, Y.-H., M. D. Layne, S. W. Chung, K. Ejima, R. M. Baron, S.-F. Yet, and M. A. Perrella. 2003. Elk-3 is a transcriptional repressor of nitric-oxide synthase 2. J. Biol. Chem. 278:39572.
20. Perrella, M. A., M. Yoshizumi, Z. Fen, J.-C. Tsai, C.-M. Hsieh, S. Kourembanas, and M.-E. Lee. 1994. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J. Biol. Chem. 269:14595.
21. Nicholson, S. C., S. R. Grobmyer, M. U. Shiloh, J. E. Brause, S. Potter, J. D. MacMicking, M. C. Dinauer, and C. F. Nathan. 1999. Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or both. Shock 4:253.
22. Cobb, J. P., and R. L. Danner. 1996. Nitric oxide and septic shock. J. Am. Med. Assoc. 275:1192.
23. Boyle, W. A. III, L. S. Parvathaneni, V. Bourlier, C. Sauter, V. E. Laubach, and J. P. Cobb. 2000. INOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ. Res. 87:E18.
24. Heremans, H., R. Dijkmans, H. Sobis, F. Vandekerckhove, and A. Billiau. 1987. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138:4175.
25. Kiener, P. A., F. Marek, G. Rodgers, P. F. Lin, G. Warr, and J. Desiderio. 1988. Induction of tumor necrosis factor, IFN-γ, and acute lethality in mice by toxic and non-toxic forms of lipid A. J. Immunol. 141:870.
26. Xie, Q., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779.
27. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730.
28. Alley, E. W., W. J. Murphy, and S. W. Russell. 1995. A classical enhancer element responsive to both lipopolysaccharide and interferon-γ augments induction of the iNOS gene in mouse macrophages. Gene 158:247.
29. Kim, Y.-M., B.-S. Lee, K.-Y. Yi, and S.-G. Paik. 1997. Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-γ plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 236:655.
30. Gao, J., D. C. Morrison, T. J. Parmely, S. W. Russell, and W. J. Murphy. 1997. An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J. Biol. Chem. 272:1226.
31. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
32. Martin, E., C. Nathan, and Q. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977.
33. Liaudet, L., A. Rosselet, M.-D. Schaller, M. Markert, C. Perret, and F. Feihl. 1998. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J. Infect. Dis. 177:127.
34. Bell, A., L. Kittler, G. Löber, and C. Zimmer. 1997. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction. J. Mol. Recognit. 10:245.
35. Pellacani, A., M. T. Chin, P. Wiesel, M. Ibanez, A. Patel, S.-F. Yet, S.-M. Hsieh, J. D. Paulauskis, R. Reeves, M.-E. Lee, and M. A. Perrella. 1999. Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1β in vascular smooth muscle cells. J. Biol. Chem. 274:1525.
36. Foster, L. C., P. Wiesel, G. S. Huggins, R. Panares, M. T. Chin, A. Pellacani, and M. A. Perrella. 2000. Role of activating protein-1 and high mobility group-I(Y) in the induction of CD44 gene expression by interleukin-1β in vascular smooth muscle cells. FASEB J. 14:368.
37. Bewley, C. A., A. M. Gronenborn, and G. M. Clore. 1998. Minor groove-binding architectural proteins: structure, function, and DNA recognition. Annu. Rev. Biophys. Biomol. Struct. 27:105.
38. Speight, R. E., D. J. Hart, and J. M. Blackburn. 2002. Distamycin A affects the stability of NF-κB p50-DNA complexes in a sequence-specific manner. J. Mol. Recognit. 15:19.
39. Spink, J., and T. Evans. 1997. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272:24417.
40. Senaldi, G., C. L. Shaklee, J. Guo, L. Martin, T. Boone, T. W. Mak, and T. R. Ulich. 1999. Protection against the mortality associated with disease models mediated by TNF and IFN-γ in mice lacking IFN regulatory factor-1. J. Immunol. 163:6820.